bioMérieux launches an avian flu test for research purposes
bioMérieux confirmed its commitment to the fight against emerging diseases and launched its avian flu detection test. Developed to respond to the needs of reference laboratories involved in the identification of the disease and in the fight against avian flu, the test, called NucliSens EasyQ® Influenza H5 and N1 is a kit of reagents exclusively for research purposes. It can detect the presence of both the H5 and N1 genetic targets in 90 minutes and will be used with the bioMérieux's NucliSens® range of molecular biology systems.
Most read news
Organizations
Other news from the department research and development

Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.